Studies suggested that S100A8 and S100A9 in the bone marrow microenvironment act as DAMPs to initiate the TLR/MyD88/NF-κB signaling axis, which is the central pathway in MDS pathogenesis [7,18]. The gene discussed is S100A9; the disease is myelodysplastic syndrome.